Showing results (71-80 of 94) with videos related to
Sort By:
Pageof 10
Cancer Research|October 15, 1992
Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expressionR J Motzer, D M Nanus, P O'Moore, et al.Cancer|September 1, 1995
Phase III randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinomaT M Law, R J Motzer, M Mazumdar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancerA D Seidman, H I Scher, J L Gabrilove, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patientsR J Motzer, M Mazumdar, J Sheinfeld, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-upP K Schultz, H W Herr, Z F Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional studyD F Bajorin, M F Sarosdy, D G Pfister, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinomaD H Ilson, R J Motzer, R L Kradin, et al.Journal of the National Cancer Institute|March 6, 1991
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologiesR J Motzer, E Rodriguez, V E Reuter, et al.Irish Journal of Medical Science|February 3, 2016
Get the GIST? An overview of gastrointestinal stromal tumoursG A Watson, D Kelly, M Melland-Smith, et al.Melanoma Research|December 1, 1992
Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanomaD F Bajorin, P B Chapman, G Y Wong, et al.Pageof 10